Reduced protein consumption
Wegovy undergoes centralized FDA oversight with pre-filled pens containing fixed doses at 0.25 mg, 0.5 mg, 1 mg, and 2.4 mg increments
Indeed, the SURPASS-CVOT study, which compares tirzepatide head-to-head with dulaglutide, will likely provide more comprehensive answers (expected by the end of 2024)
If it still will not clarify, the peptide may be compromised
It is a critical clinical process that determines how well patients tolerate the medication, how effectively it reduces hunger or cravings, and how smoothly their weight loss journey begins
Semaglutide, the active ingredient in Ozempic and Wegovy, and tirzepatide, the active ingredient in Mounjaro and Zepbound, have shifted this paradigm